Ollin Biosciences is hiring for a role in the CMC engine behind next-generation ophthalmology therapeutics, including process development, validation, tech transfer, and BLA submission for Phase 3 assets in nAMD and DME, plus an earlier-stage thyroid eye disease program.
Public source
Publisher name
Public post
We're hiring! Join us as we build the CMC engine behind next-generation ophthalmology therapeutics. From process development to validation, tech transfer, and BLA submis…
Company
Ollin Biosciences
Accelerating Next Generation Therapies for Ophthalmology
- Industry
- Biotechnology Research
- Location
- Austin, US
- Company size
- 11–50 employees
About Ollin Biosciences
Ollin Biosciences is a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases. With a differentiated pipeline, world-class team, and strong investor syndicate, Ollin is redefining what’s possible in ophthalmology.
See moreDiscover more
Similar signals
Similar public activity from other companies.
People
Balance Ophthalmics
Balance Ophthalmics is hiring 5 Founding U.S. Strategic Account Managers to join the company at a pivotal moment in ophthalmology.
People
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. is hiring a hands-on regulatory professional with strong CMC technical knowledge for small molecule and antisense oligonucleotide programs.
People
Forge Biologics
Forge Biologics is hiring a Director, Quality Control (Raw Materials) to drive strategic direction and tactical execution of QC Raw Materials.
People
Oblenio Bio
Oblenio Bio is hiring for a VP, Head of Regulatory Affairs role.
People
Kincell Bio